Chris Counihan analyst JEFFERIES

Currently out of the existing stock ratings of Chris Counihan, 8 are a HOLD (72.73%), 3 are a BUY (27.27%).

Chris Counihan

Work Performance Price Targets & Ratings Chart

Analyst Chris Counihan, currently employed at JEFFERIES, carries an average stock price target met ratio of 16.67% that have a potential upside of 27.51% achieved within 93 days.

Chris Counihan’s has documented 20 price targets and ratings displayed on 2 stocks.

Most recent stock forecast was given on LNXSF, Lanxess AG at 21-Jun-2023.

Wall Street Analyst Chris Counihan

Analyst best performing recommendations are on LNXSF (LANXESS AG).
The best stock recommendation documented was for LNXSF (LANXESS AG) at 3/12/2020. The price target of $58.33 was fulfilled within 186 days with a profit of $20.7 (55.01%) receiving and performance score of 2.96.

Average potential price target upside

COVTY Covestro ADR LNXSF Lanxess AG

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 27-Jul-2020

$43.3

$9.19 (26.94%)

$78.63

2 years 9 months 18 days ago
(28-Mar-2023)

0/5 (0%)

$23.28 (116.28%)

Hold

Since 26-Apr-2021

$45.81

$11.7 (34.30%)

$79.59

2 years 10 months 9 days ago
(06-Mar-2023)

0/2 (0%)

$25 (120.13%)

Buy

Since 08-Mar-2019

$62.64

$28.53 (83.64%)

$58.16

2 years 10 months 12 days ago
(03-Mar-2023)

0/15 (0%)

$41.29 (193.40%)

Buy

Since 20-Jan-2023

$52.14

$18.03 (52.86%)

$30.22

2 years 11 months 26 days ago
(20-Jan-2023)

1/4 (25%)

$29.54 (130.71%)

698

Hold

Since 13-Jan-2023

$37

$2.89 (8.47%)

$57.48

3 years 2 days ago
(13-Jan-2023)

0/2 (0%)

$15.14 (69.26%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Chris Counihan?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?